[HTML][HTML] Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics

D Rudin, ME Liechti, D Luethi - Experimental neurology, 2021 - Elsevier
New psychoactive stimulants and psychedelics continue to play an important role on the
illicit new psychoactive substance (NPS) market. Designer stimulants and psychedelics both …

Organic cation transporters in psychiatric and substance use disorders

LE Honan, R Fraser-Spears, LC Daws - Pharmacology & therapeutics, 2024 - Elsevier
Psychiatric and substance use disorders inflict major public health burdens worldwide. Their
widespread burden is compounded by a dearth of effective treatments, underscoring a dire …

Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors

R Gradisch, K Schlögl, E Lazzarin, M Niello… - Nature …, 2024 - nature.com
The presynaptic serotonin transporter (SERT) clears extracellular serotonin following
vesicular release to ensure temporal and spatial regulation of serotonergic signalling and …

Persistent binding at dopamine transporters determines sustained psychostimulant effects

M Niello, S Sideromenos, R Gradisch… - Proceedings of the …, 2023 - National Acad Sciences
Psychostimulants interacting with the dopamine transporter (DAT) can be used illicitly or for
the treatment of specific neuropsychiatric disorders. However, they can also produce severe …

A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions

S Kouhnavardi, A Ecevitoglu, V Dragačević, F Sanna… - Biomolecules, 2022 - mdpi.com
Dopamine (DA), the most abundant human brain catecholaminergic neurotransmitter,
modulates key behavioral and neurological processes in young and senescent brains …

Development and validation of an automated microfluidic perfusion platform for parallelized screening of compounds in vitro

FR Brugnoli, M Holy, M Niello, J Maier… - Basic & Clinical …, 2023 - Wiley Online Library
Monoamine transporters are of great interest for their role in the physiological activity of the
body and their link to mental and behavioural disorders. Currently, static well‐plate assays …

(2-Aminopropyl) benzo [β] thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice

D Rudin, JD McCorvy, GC Glatfelter, D Luethi… - …, 2022 - nature.com
Abstract Derivatives of (2-aminopropyl) indole (API) and (2-aminopropyl) benzofuran (APB)
are new psychoactive substances which produce stimulant effects in vivo.(2-Aminopropyl) …

Structure–Activity Relationship of Synthetic Cathinones: An Updated Review

N Nadal-Gratacós, MD Pazos, D Pubill… - ACS Pharmacology & …, 2024 - ACS Publications
The escalating prevalence of new psychoactive substances (NPSs) poses a significant
public health challenge, evidenced by the vast chemical diversity, with over 500 substances …

Interaction profiles of central nervous system active drugs at human organic cation transporters 1–3 and human plasma membrane monoamine transporter

TJF Angenoorth, S Stankovic, M Niello, M Holy… - International Journal of …, 2021 - mdpi.com
Many psychoactive compounds have been shown to primarily interact with high-affinity and
low-capacity solute carrier 6 (SLC6) monoamine transporters for norepinephrine (NET; …

Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties

P Puigseslloses, N Nadal-Gratacós, G Ketsela… - Molecular …, 2024 - nature.com
Recent studies have sparked renewed interest in the therapeutic potential of psychedelics
for treating depression and other mental health conditions. Simultaneously, the novel …